Glenmark Pharmaceuticals Ltd :

570.30 -3.45 [-0.60%]

ISIN: INE935A01035 | NSE: GLENMARK | Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln | BSE Code: 532296 | Comments

Price Information
• Open	570.10
• High	578.45
• Low	570.00
• Previous Close	573.75
• Shares Traded	8916
• 52 Wk High Price	607.70
• 52 Wk High Date	20-05-2013
• 52 Wk Low Price	332.45
• 52 Wk Low Date	21-05-2012
• Face Value	1.00

Fundamentals
• Market Capital (Rs.cr)	15498.20
• EPS (Rs.)(TTM)	14.30
• P/E Ratio(TTM)	40.00
• Book Value (Rs.)	93.10
• Price to Book Value	6.14
• Equity (Rs.cr.)	27.09
• Traded Value (Rs.lac)	198.44

Corporate Actions
Ex-Date	Purpose (Rs.)
2011-07-28	40% Dividend (0.4)
2012-07-19	200% Dividend (2)

Index Names
• BSE-100
• BSE-200
• BSE-500
• BSE HC
• CNX Nifty Jr.

Related Companies
Stock Name	Price

CIPLA	415.25
JBCHEPHARM	84.10
PIRHEALTH	573.00
RANBAXY	433.55
UNICHEMLAB	180.30
ALEMBICLTD	19.85
LYKALABS	9.12
TTKHEALTH	536.20
DRREDDY	2043.20
SOLPHARMA	9.65	-

Share Tips for Glenmark Pharmaceuticals Ltd

stocks to buy today : Buy Bata, Glenm (07:56AM, May 10 '13)

Morning capsule: Things to know before (09:31AM, May 07 '13)

GLENMARK PHARMA CALL>>>>>>>>>>>>>>>>>> (03:18PM, Apr 12 '13)

GLENMARK PHARMA CALL>>>>>>>>>>>>>>>>>> (10:51AM, Apr 02 '13)

GLENMARK PHARMA CALL>>>>>>>>>>>>>>>>>> (09:21AM, Mar 28 '13)

Mutual funds holding in Glenmark Pharmaceuticals Ltd

Escorts Growth Plan - Growth

Morgan Stanley Growth Fund - Growth

SBI Magnum Sector Umbrella - Pharma Fund - Growth

Principal Emerging Bluechip Fund - Growth

ING C.U.B. Fund - Growth

Key Financials	Latest Qrtr.	Trailing Yr.	Full Yr.
• Year End	Mar, 2013	Mar, 2013	Mar, 2013
• Sales (Rs.cr)	484.14	1935.29	1935.29
• Net Profit (Rs.cr)	84.92	386.11	386.11
• Net Profit Var (%)	-43.00	45.00	45.00
• EPS (Rs)	-	14.30	14.30
• P/E Ratio	-	40.00	40.00
• Operating Profit Margin	-	17.20	-
• CPS (Rs.)	-	-	15.20
• P/C Ratio	-	-	37.70
• Div%	-	-	200.00

Announcements
24-12-2012	Forest Laboratories & Glenmark Pharmaceuticals sign development agreement for worldwide collaborat
22-10-2012	Glenmark Pharmaceuticals received tentative approval for Telmisartan tablets
04-02-2013	Glenmark announces discovery and initiation of IND enabling studies of GBR 830 GBR 830 is the fi
08-02-2011	Glenmark announces positive results from the multi-centre study of Crofelemer
08-11-2010	Glenmark confirms patent infringement suit for
19-11-2010	Glenmark Pharmaceuticals allots equity shares
27-10-2010	Glenmark Pharmaceuticals allots shares
21-03-2013	Glenmark Pharmaceuticals allots stock options
13-09-2012	Glenmark Pharmaceuticals announces the initiation of Phase II Study for GBR 500 for Ulcerative Colit
31-01-2012	Glenmark Pharmaceuticals appoints additional directors
09-11-2011	Glenmark Pharmaceuticals appoints director
23-01-2012	Glenmark Pharmaceuticals gets UK MHRA nod for Rizatriptan Benzonate tablets
10-12-2011	Glenmark Pharmaceuticals issues stock options
02-04-2011	Glenmark Pharmaceuticals issues stok options
09-05-2012	Glenmark Pharmaceuticals recommends dividend
16-07-2011	Glenmark Pharmaceuticals to announce Q1 results
01-11-2011	Glenmark Pharmaceuticals to announce Q2 results
24-01-2011	Glenmark Pharmaceuticals to announce Q3 results

Gross Deliverables

Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover

20-05-2013 23658 123142 19.21 13563131 72521.40
17-05-2013 12223 34944 34.98 6992778 19844.40
13-05-2013 15530 59257 26.21 8281372 32164.10
11-05-2013 1368 2727 50.17 738515 1468.87
10-05-2013 34317 144342 23.77 18520885 78365.60

Block Deals

Deal Date Client Name Type Qty Price

06-11-2012 THE ROYAL BANK OF SCOTLAND ASIA MERCHANT BANK SINGAPORE LT B 815685 438.10
06-11-2012 ABN AMRO BANK NV S 815685 438.10
25-10-2012 THE ROYAL BANK OF SCOTLAND ASIA MERCHANT BANK SINGAPORE LT B 400000 399.00
25-10-2012 ABN AMRO BANK NV S 400000 399.00

Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action

Comment(s) posted on Glenmark Pharmaceuticals Ltd

Hot Searches • automobiles • sundar • astrazen • prraneta • hindi • fame • aptech • mmtc • ucobank • lanco

Date	Del. Shares	Trd. Qty.	Del.(%)	Del. Value	Turnover
20-05-2013	23658	123142	19.21	13563131	72521.40
17-05-2013	12223	34944	34.98	6992778	19844.40
13-05-2013	15530	59257	26.21	8281372	32164.10
11-05-2013	1368	2727	50.17	738515	1468.87
10-05-2013	34317	144342	23.77	18520885	78365.60

Deal Date	Client Name	Type	Qty	Price
06-11-2012	THE ROYAL BANK OF SCOTLAND ASIA MERCHANT BANK SINGAPORE LT	B	815685	438.10
06-11-2012	ABN AMRO BANK NV	S	815685	438.10
25-10-2012	THE ROYAL BANK OF SCOTLAND ASIA MERCHANT BANK SINGAPORE LT	B	400000	399.00
25-10-2012	ABN AMRO BANK NV	S	400000	399.00